Free Trial
→ The world’s first multi- trillion-dollar robotics industry … (From Weiss Ratings) (Ad) Buy GHRS Stock  Free GHRS Stock Alerts

GH Research (GHRS) Financials

GH Research logo
$11.39 +0.62 (+5.76%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$10.56 -0.83 (-7.29%)
As of 05/2/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for GH Research

Annual Income Statements for GH Research

This table shows GH Research's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -0.31 -0.45 -9.20 -22 -36 -39
Consolidated Net Income / (Loss)		 -0.31 -0.45 -9.20 -22 -36 -39
Net Income / (Loss) Continuing Operations		 -0.31 -0.45 -9.20 -22 -36 -39
Total Pre-Tax Income 		-0.31 -0.45 -9.20 -22 -36 -39
Total Operating Income		 -0.31 -0.45 -15 -31 -41 -50
Total Gross Profit		 0.00 0.00 0.00 0.00 0.00 0.00
Total Revenue		 0.00 0.00 0.00 0.00 0.00 0.00
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 0.31 0.45 15 31 41 50
Selling, General & Admin Expense		 0.01 0.11 6.55 10 11 15
Research & Development Expense		 0.30 0.34 8.55 20 30 35
Total Other Income / (Expense), net		 0.00 0.00 5.90 8.22 5.63 11
Interest Expense		 - - 0.01 0.12 0.72 0.72
Interest & Investment Income		 - - 0.00 1.17 8.98 9.87
Other Income / (Expense), net		 0.00 0.00 5.91 7.18 -2.62 2.13
Income Tax Expense		 0.00 0.00 0.00 0.00 0.00 0.00
Basic Earnings per Share		 ($0.01) ($0.02) ($0.21) ($0.43) ($0.68) ($0.75)
Weighted Average Basic Shares Outstanding		 - - 52.02M 52.02M 52.03M 52.03M
Diluted Earnings per Share		 ($0.01) ($0.02) ($0.21) ($0.43) ($0.68) ($0.75)
Weighted Average Diluted Shares Outstanding		 - - 52.02M 52.02M 52.03M 52.03M
Weighted Average Basic & Diluted Shares Outstanding		 - - 52.02M 52.02M 52.03M 52.03M

Quarterly Income Statements for GH Research

No quarterly income statements for GH Research are available.

Annual Cash Flow Statements for GH Research

This table details how cash moves in and out of GH Research's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 0.51 5.17 271 -111 -88 23
Net Cash From Operating Activities		 -0.29 -0.33 -15 -26 -33 22
Net Cash From Continuing Operating Activities		 -0.29 -0.33 -15 -25 -26 22
Net Income / (Loss) Continuing Operations		 -0.31 -0.45 -9.20 -22 -36 -39
Consolidated Net Income / (Loss)		 -0.31 -0.45 -9.20 -22 -36 -39
Depreciation Expense		 0.00 0.00 0.02 0.05 0.32 0.32
Non-Cash Adjustments To Reconcile Net Income		 0.02 0.12 -6.09 -3.22 4.91 61
Net Cash From Investing Activities		 0.00 0.00 -0.10 -85 -54 -0.05
Net Cash From Continuing Investing Activities		 0.00 0.00 -0.10 -85 -54 -0.05
Purchase of Property, Plant & Equipment		 0.00 0.00 -0.10 -0.07 -0.10 -0.05
Net Cash From Financing Activities		 0.80 5.50 286 0.00 -0.20 0.00
Net Cash From Continuing Financing Activities		 0.80 5.50 286 0.00 -0.20 0.00

Quarterly Cash Flow Statements for GH Research

No quarterly cash flow statements for GH Research are available.

Annual Balance Sheets for GH Research

This table presents GH Research's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 5.91 280 254 226 188
Total Current Assets		 5.91 280 169 164 154
Cash & Equivalents		 5.90 277 166 78 101
Other Current Assets		 0.02 3.07 2.59 2.53 4.90
Other Current Nonoperating Assets		 - - 0.00 56 19
Plant, Property, & Equipment, net		 0.00 0.00 0.10 1.07 0.75
Plant, Property & Equipment, gross		 0.00 - 0.10 1.07 0.75
Total Noncurrent Assets		 0.00 0.08 0.00 0.00 0.00
Total Liabilities & Shareholders' Equity		 5.91 280 254 226 188
Total Liabilities		 0.25 2.75 4.55 7.33 9.32
Total Current Liabilities		 0.25 2.75 4.55 6.70 8.95
Accounts Payable		 0.00 0.88 1.87 3.49 3.74
Other Current Liabilities		 0.25 1.87 2.68 3.21 5.21
Total Noncurrent Liabilities		 0.00 0.00 0.00 0.63 0.37
Capital Lease Obligations		 - - 0.00 0.63 0.37
Total Equity & Noncontrolling Interests		 5.67 277 250 219 179
Total Preferred & Common Equity		 5.67 277 250 219 179
Total Common Equity		 5.67 277 250 219 179
Common Stock		 6.30 1.30 293 293 293
Retained Earnings		 -0.84 -10 -32 -68 -106
Other Equity Adjustments		 0.20 286 -10 -5.86 -7.37

Quarterly Balance Sheets for GH Research

No quarterly balance sheets for GH Research are available.

Annual Metrics and Ratios for GH Research

This table displays calculated financial ratios and metrics derived from GH Research's official financial filings.

Metric 2019 2020 2021 2022 2023 2024
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth		 0.00% -43.87% -1,956.95% -154.32% -83.47% -11.83%
EBIT Growth		 0.00% -43.87% -1,961.21% -154.30% -87.54% -9.90%
NOPAT Growth		 0.00% -43.87% -3,285.65% -102.34% -34.92% -22.05%
Net Income Growth		 0.00% -43.87% -1,963.23% -144.03% -58.47% -9.48%
EPS Growth		 0.00% -45.45% -1,212.50% -104.76% -58.14% -10.29%
Operating Cash Flow Growth		 0.00% -14.19% -4,531.21% -71.43% -27.24% 167.22%
Free Cash Flow Firm Growth		 0.00% 0.00% -13,359.13% -70.80% -44.39% -26.80%
Invested Capital Growth		 0.00% 0.00% 274.24% -566.92% -66.56% -6.48%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 100.00% 100.00% 100.10% 96.06% 81.17% 80.86%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 0.00% -7.87% -6.51% -8.52% -15.18% -19.58%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% -2,806.52% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 0.00% -7.87% -6.51% -8.52% -15.18% -19.58%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -7.87% -3.32% -8.99% -16.25% -21.77%
Net Operating Profit after Tax (NOPAT)		 -0.22 -0.31 -11 -21 -29 -35
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 0.00% -4.54% 0.97% -0.40% -2.84% -1.85%
Return On Investment Capital (ROIC_SIMPLE)		 - - - -8.56% -13.14% -19.64%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -0.31 -0.45 -9.19 -23 -44 -48
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -0.31 -0.45 -9.17 -23 -43 -48
Valuation Ratios		 - - - - - -
Price to Book Value (P/BV)		 0.00 28.24 0.84 2.02 1.38 2.04
Price to Tangible Book Value (P/TBV)		 0.00 28.24 0.84 2.02 1.38 2.04
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 11.77
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 0.00 -1.04 -1.00 -1.00 -1.01 -1.02
Leverage Ratio		 0.00 1.04 1.01 1.01 1.03 1.04
Compound Leverage Factor		 0.00 1.04 1.01 0.97 0.83 0.84
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.29% 0.21%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.29% 0.21%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 100.00% 100.00% 100.00% 99.71% 99.79%
Debt to EBITDA		 0.00 0.00 0.00 0.00 -0.01 -0.01
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 1.82 2.10
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 -0.01 -0.01
Debt to NOPAT		 0.00 0.00 0.00 0.00 -0.02 -0.01
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 2.70 2.85
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 -0.02 -0.01
Altman Z-Score		 0.00 390.95 51.95 67.03 24.47 22.73
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - -
Current Ratio		 0.00 24.03 101.80 37.07 24.49 17.23
Quick Ratio		 0.00 23.96 100.68 36.51 11.70 11.26
Cash Flow Metrics		 - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -0.08 -11 -19 -28 -35
Operating Cash Flow to CapEx		 0.00% 0.00% -14,695.19% -39,102.99% -33,336.00% 45,728.57%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 -1,244.22 -155.49 -38.20 -48.84
Operating Cash Flow to Interest Expense		 0.00 0.00 -1,698.11 -213.00 -46.11 31.25
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 -1,709.67 -213.54 -46.25 31.18
Efficiency Ratios		 - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - -
Invested Capital		 0.00 -0.23 0.40 -1.86 -3.10 -3.30
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 0.00 -0.23 0.63 -2.26 -1.24 -0.20
Enterprise Value (EV)		 0.00 154 -43 340 224 264
Market Capitalization		 160 160 233 506 302 364
Book Value per Share		 $0.00 $0.57 $5.33 $4.80 $4.21 $3.44
Tangible Book Value per Share		 $0.00 $0.57 $5.33 $4.80 $4.21 $3.44
Total Capital		 0.00 5.67 277 250 220 179
Total Debt		 0.00 0.00 0.00 0.00 0.63 0.37
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.63 0.37
Net Debt		 0.00 -5.90 -277 -166 -78 -100
Capital Expenditures (CapEx)		 0.00 0.00 0.10 0.07 0.10 0.05
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -0.23 0.32 -1.96 79 44
Debt-free Net Working Capital (DFNWC)		 0.00 5.67 277 164 157 145
Net Working Capital (NWC)		 0.00 5.67 277 164 157 145
Net Nonoperating Expense (NNE)		 0.09 0.13 -1.37 1.07 6.73 3.74
Net Nonoperating Obligations (NNO)		 0.00 -5.90 -277 -252 -222 -182
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.02 0.05 1.04 0.32
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($0.21) $0.00 ($0.68) ($0.75)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 52.02M 0.00 52.03M 52.03M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($0.21) $0.00 ($0.68) ($0.75)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 52.02M 0.00 52.03M 52.03M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 52.02M 0.00 52.03M 52.03M
Normalized Net Operating Profit after Tax (NOPAT)		 -0.22 -0.31 -11 -21 -29 -35
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - - - -
EBIT to Interest Expense		 0.00 0.00 -1,021.44 -190.07 -60.64 -67.20
NOPAT to Interest Expense		 0.00 0.00 -1,174.44 -173.88 -39.91 -49.12
EBIT Less CapEx to Interest Expense		 0.00 0.00 -1,033.00 -190.61 -60.78 -67.27
NOPAT Less CapEx to Interest Expense		 0.00 0.00 -1,186.00 -174.43 -40.05 -49.19
Payout Ratios		 - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% -247.26% 0.00% 0.00% 0.00%

Quarterly Metrics and Ratios for GH Research

No quarterly metrics and ratios for GH Research are available.

Frequently Asked Questions About GH Research's Financials

When does GH Research's fiscal year end?

According to the most recent income statement we have on file, GH Research's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has GH Research's net income changed over the last 5 years?

GH Research's net income appears to be on an upward trend, with a most recent value of -$38.96 million in 2024, rising from -$310 thousand in 2019. The previous period was -$35.59 million in 2023. View GH Research's forecast to see where analysts expect GH Research to go next.

What is GH Research's operating income?
GH Research's total operating income in 2024 was -$50.31 million, based on the following breakdown:
  • Total Gross Profit: $0.00
  • Total Operating Expenses: $50.31 million
How has GH Research revenue changed over the last 5 years?

Over the last 5 years, GH Research's total revenue changed from $0.00 in 2019 to $0.00 in 2024, a change of 0.0%.

How much debt does GH Research have?

GH Research's total liabilities were at $9.32 million at the end of 2024, a 27.1% increase from 2023, and a 3,689.4% increase since 2020.

How much cash does GH Research have?

In the past 4 years, GH Research's cash and equivalents has ranged from $5.90 million in 2020 to $276.78 million in 2021, and is currently $100.79 million as of their latest financial filing in 2024.

How has GH Research's book value per share changed over the last 5 years?

Over the last 5 years, GH Research's book value per share changed from 0.00 in 2019 to 3.44 in 2024, a change of 344.0%.


Related Companies

This page (NASDAQ:GHRS) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners
Think NVDA’s run was epic? You ain’t seen nothin’ yet
Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...
Timothy Sykes | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...
Porter & Company | Sponsored
Elon’s Terrifying Warning Forces Trump To Take Action
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...
American Hartford Gold | Sponsored
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
Most traders are panicking. We’re cashing in
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....
Crypto Swap Profits | Sponsored
DOGE officially begins retirement transformation
Elon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...
Altimetry | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...
Weiss Ratings | Sponsored